PLZ4-coated paclitaxel-loaded micelles

PLZ4-coated paclitaxel-loaded micelles (PPM) is a novel nanotherapeutic formulation designed specifically for bladder cancer treatment. This innovative drug combines targeted delivery with chemotherapy to improve efficacy while reducing toxicity. PPM is a solvent-free injectable nanoscale micelle formulation of paclitaxel (PTX)[1]. The micelles are decorated with PLZ4, a bladder cancer-specific targeting ligand, on their surface[5]. This design allows the drug to selectively deliver its paclitaxel payload into bladder cancer cells following administration[6]. The key advantages of this formulation include: 1. **Cancer-specific targeting**: PLZ4 can specifically guide the micelles to target and deliver paclitaxel into bladder cancer cells[7]. 2. **Improved solubility**: Traditional paclitaxel formulations require Cremophor EL (polyoxyethylated castor oil/ethanol), which is associated with severe allergic reactions in patients. The micelle formulation eliminates this need[5]. 3. **Enhanced efficacy**: Preclinical studies showed that formulating paclitaxel in micelles could significantly increase efficacy while decreasing toxicity, allowing for administration of higher doses (two to three times the maximum tolerated dose)[5].

Other names

PPM